Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

TORRANCE, Calif., May 15, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months…